UBS Group AG - CALLIDITAS THERAPEUTICS AB ownership

CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 16 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CALLIDITAS THERAPEUTICS AB
ValueSharesWeighting
Q3 2023$749
-73.3%
41
-76.8%
0.00%
Q2 2023$2,804
-61.8%
177
-42.2%
0.00%
Q1 2023$7,335
-3.9%
306
-31.8%
0.00%
Q4 2022$7,633
+90.8%
449
+73.4%
0.00%
Q3 2022$4,000
-63.6%
259
-59.3%
0.00%
Q2 2022$11,000
-62.1%
636
-57.3%
0.00%
Q1 2022$29,000
-19.4%
1,490
+2.3%
0.00%
Q4 2021$36,000
+800.0%
1,457
+799.4%
0.00%
Q3 2021$4,000162
+1372.7%
0.00%
Q2 2021$0
-100.0%
11
-98.4%
0.00%
Q1 2021$19,000
-5.0%
691
-17.3%
0.00%
Q3 2020$20,0008360.00%
Other shareholders
CALLIDITAS THERAPEUTICS AB shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 750,000$13,695,0000.37%
IRONWOOD INVESTMENT MANAGEMENT LLC 26,688$487,3230.30%
SPHERA FUNDS MANAGEMENT LTD. 11,863$216,6180.04%
Nalls Sherbakoff Group, LLC 35$6400.00%
DEUTSCHE BANK AG\ 90,550$1,653,4430.00%
Citadel Advisors 2,700$49,3020.00%
Citadel Advisors 5,500$100,4300.00%
Citadel Advisors 4,958$90,5330.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 22,100$403,5460.00%
SIMPLEX TRADING, LLC 536$90.00%
View complete list of CALLIDITAS THERAPEUTICS AB shareholders